Biomedical Science versus Biomedicine, a Continuing Series
A case study of biomedical science progress against cystic fibrosis, and the resulting “biomedicine” profiteering.
Read more...A case study of biomedical science progress against cystic fibrosis, and the resulting “biomedicine” profiteering.
Read more...Who’s regulating Telehealth drug sales?
Read more...Some employers in primary care deserts are entering the healh care business, indirectly revealing the level of institutionalized profiteering
Read more...Flu vaccine upselling as yet another chapter in medicine, American-style.
Read more...An in-depth look at two important advances in biomedical science, each treating a dangerous genetic disease.
Read more...A look at how different communities are deploying opioid settlement cash. But no clear data on policing versus treatment.
Read more...A year of health-insurance adjustments pushed down core CPI and core services CPI; inflation adjustments swing the other way next month.
Read more...The U.S. health care industry is one of the world’s worst polluters, causing many of the deaths it seeks to prevent.
Read more...An overview of the issues in and the magnitude of the strike at the Kaiser health system.
Read more...Dollar General has launched profit-motivated health clinics on wheels. What could go wrong?
Read more...The FIRE sector capitalizes on Germany’s industrial decline as government diverts money from social programs to military.
Read more...Sadly, famed short seller David Einhorn’s saying applies to US public health: “No matter how bad you think it is, it’s worse.”
Read more...Simon Schama’s book on pandemics and vaccines is highly informative, although KLG takes issue with Schama’s defense of Anthony Fauci.
Read more...The researchers found that former Medicaid enrollees looking for health plans on the private market face aggressive, misleading marketing of limited-benefit products that don’t cover important services and fail to protect consumers from high health costs.
Read more...The cheap and highly addictive cocaine-like stimulant Captagon shows signs of following in the opioid fentanyl’s footsteps.
Read more...